Cited by 106Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

Astrocytic degeneration relates to the severity of disease in frontotemporal dementia

Broe, M.·2004·Brain

Abstract

The main unifying feature of cases with frontotemporal dementia (FTD) is the pattern of brain atrophy. Surprisingly, there are a variety of underlying histopathologies in cases with the clinical features and typical pattern of atrophy characterizing FTD. This suggests that the degenerative mechanism(s) associated with pyramidal cell loss and gliosis in FTD is likely to be similar in the different histopathological forms of the disease. In this study we tested this hypothesis by analysing a common cell death mechanism, apoptosis, in cases of FTD with either Pick's disease (PiD) (n = 9) or frontotemporal lobar degeneration (FTLD) (n = 7) compared with normal controls (n = 10). Tissue sections from previously analysed cases were stained using anti-activated caspase-3 immunohistochemistry, TUNEL, propidium iodide, and cell- and pathology-specific labels. These markers of apoptosis identified both astrocytes and neurons in regions vulnerable to degeneration in all cases of FTD. However, neuronal apoptosis was rare (<2% of neurons), even at early disease stages where there is considerably less frontotemporal atrophy or pyramidal cell loss. This suggests that other cell death mechanisms account for the progressive neuronal loss in FTD. In contrast, astrocytes with beaded processes and other apoptotic features were very frequent in both PiD and FTLD, with the severity of astrocytosis and astrocytic apoptosis correlating with both the degree of neuronal loss and the stage of disease. These findings provide evidence that astrocytic apoptosis occurs as an early event in different histopathological forms of FTD. Furthermore, this astrocytic apoptosis directly relates to the degree of degeneration in FTD, and becomes the overwhelming pathological feature as the disease progresses.

Integrity signals

Registry

Crossref · 10.1093/brain/awh250

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Broe, M.
Affiliations
The University of Sydney (AU)
Corresponding author
Broe, M.
Venue
Brain
Published
2004-09-13
Volume
127
Issue
10
Pages
2214-2220
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2124124662
Cited by
106
References
20
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 13 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 4 · 2012: 5
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Locations
  • Brain (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Health and Medical Research Council
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal dementia, Pick's disease, frontotemporal lobar degeneration, neuronal apoptosis, astrocyte activation, caspase-3, TUNEL, neuronal loss, disease severity, brain atrophy, gliosis
MeSH terms
Aged, Aged, 80 and over, Astrocytes, Atrophy, Brain, Dementia, Female, Gliosis, Humans, Immunohistochemistry, Male, Middle Aged, Neuroglia, Neurons, Propidium, Severity of Illness Index, Biomarkers, Apoptosis, Caspases, In Situ Nick-End Labeling, Pick Disease of the Brain, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review